Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NIQZP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
chMC-813-70-VC-PAB-MMAE
|
|||||
| Synonyms |
chMC-813-70-VC-PAB-MMAE
Click to Show/Hide
|
|||||
| Organization |
The Scripps Research Institute.; Academia Sinica.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Structure |
|
|||||
| Antibody Name |
chMC-813-70
|
Antibody Info | ||||
| Antigen Name |
Stage-specific embryonic antigen-4 (SSEA4)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
DBCO-PEG4-Val-Cit-PABC
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
General Information of The Activity Data Related to This ADC
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.211 nM | Positive HER2 expression (HER2+++/++) | ||
| Method Description |
Having ADCs with cleavable and non-cleavable linkers in place, we next assessed there in vitro cytotoxicity activities using SSEA4-expressing ovarian SKVO3 cells and breast cancer cells SKBR3 with a negligible expression of SSEA4 and 293T cells as a control. SK-OV3, SKBR3, and 293T cells (2×103 cells/well) were incubated with ADC-1, ADC-2, and chMC-813-70 for 72 h and then treated with MTS at 37 °C. The conversion of the tetrazolium salt MTS (3- (4,5-dimethylthiazol-2-yl)-5- (3-carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium) to a purple formazan, as a measure of the percentage of viable cells, was measured by absorbance at 490 nm after 4 h. The untreated cells' absorbance was considered 100 % survival (Figure 4).
Click to Show/Hide
|
||||
| In Vitro Model | Ovarian serous adenocarcinoma | SKOV-3 cells | CVCL_0532 | ||
References
